Societal CDMO Inc
F:RAH

Watchlist Manager
Societal CDMO Inc Logo
Societal CDMO Inc
F:RAH
Watchlist
Price: 1.58 EUR Market Closed
Market Cap: 165.5m EUR

Societal CDMO Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Societal CDMO Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Societal CDMO Inc
F:RAH
Free Cash Flow
-$9.2m
CAGR 3-Years
N/A
CAGR 5-Years
30%
CAGR 10-Years
-27%
Johnson & Johnson
NYSE:JNJ
Free Cash Flow
$19.6B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Free Cash Flow
$15.3B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
31%
Pfizer Inc
NYSE:PFE
Free Cash Flow
$10.4B
CAGR 3-Years
-24%
CAGR 5-Years
0%
CAGR 10-Years
-3%
Merck & Co Inc
NYSE:MRK
Free Cash Flow
$13B
CAGR 3-Years
-5%
CAGR 5-Years
14%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Free Cash Flow
$6.4B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
14%
No Stocks Found

Societal CDMO Inc
Glance View

Market Cap
165.7m EUR
Industry
Pharmaceuticals

Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The company is headquartered in Exton, Pennsylvania and currently employs 258 full-time employees. The company went IPO on 2014-03-07. Societal CDMO is principally focused on solving various manufacturing problems. The company is a CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. In addition to its experience in handling Drug Enforcement Agency (DEA) controlled substances and developing and manufacturing modified-release dosage forms, the Company has the ability to deliver on its clients pharmaceutical development and manufacturing projects. The company conducts its operations in Gainesville, Georgia and San Diego, California.

RAH Intrinsic Value
Not Available

See Also

What is Societal CDMO Inc's Free Cash Flow?
Free Cash Flow
-9.2m USD

Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Free Cash Flow amounts to -9.2m USD.

What is Societal CDMO Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-27%

Over the last year, the Free Cash Flow growth was 23%.

Back to Top